Tag: ANDA approval
Deficiency Letters in Generic Applications: Common FDA Findings and How to Avoid Them
FDA deficiency letters are a major hurdle for generic drugmakers. Learn the top 5 reasons applications get flagged - from dissolution issues to impurity controls - and how to avoid costly delays.
Predicting Generic Entry: How to Forecast When Your Drug Will Face Generic Competition
Learn how to predict when generic drugs will enter the market after patent expiry. Understand the legal, regulatory, and economic factors that delay or speed up generic competition-and how it affects drug prices and patient access.